Chapter 24 Novartis’ conditions
Lu Liang was so engrossed in checking documents that he didn't even notice that it was already evening.
When Lu Liang noticed that it was getting dark, it was already past eight o'clock in the evening.
A feeling of emptiness came from his stomach, and hunger kept reminding Lu Liang that he urgently needed to eat now.
Lu Liang put his things into his backpack and walked out of the library. He began to think about where he should go to eat.
At this time, the cafeteria must have been closed, so the next step is to go to the snack street behind the school.
At this moment, the snack street was brightly lit, and the roar of people drowned out the shouts of the speakers on the street.
Lu Liang came to a small shop, casually asked for a pancake and fruit, and then asked the boss to add two eggs.
Since the drug was sold, the profit share has been continuously transferred to Lu Liang's bank card.
Although after excluding the cost of the pharmaceutical factory and the funding of the research team, the profit that Lu Liang can share is not much.
But for Lu Liang now, it is still an astronomical sum.
Just as Lu Liang was standing in front of the pancake and fruit stall waiting, a ringtone suddenly came from his cell phone. ,
Lu Liang took out his cell phone and looked at it, and unexpectedly found that it was a call from Ji Hong.
It's so late. Is there anything wrong with Ji Hong calling?
Lu Liang didn't think much, he answered the phone: Teacher Ji, what's the matter?
Ji Hong's voice came from the other end of the phone: Xiao Lu, there is something that may require you to make a decision.
Ji Hong's voice sounded very serious, which made Lu Liang frown: Teacher, tell me.
Ji Hong spoke slowly at this time: Xiao Lu, you should know Novartis, right?
How could Lu Liang not have heard of Novartis, a multinational pharmaceutical company, one of the giants of Western medicine, and the manufacturer of Gleevec?
I know, what's wrong, teacher? Lu Liang asked.
Ji Hong took a deep breath and said: Today, the pharmaceutical representative of Novartis came to see me.
Novartis pharmaceutical representative?
Lu Liang was stunned for a moment. Although he guessed that Novartis would come to the door sooner or later, he did not expect it to be so soon.
Ji Hong continued: Novartis came to me and said it wanted to buy Bai Shuke's patent. Xiao Lu, the patent is yours and the decision is in your hands. Do you have any ideas?
After listening to Ji Hong's words, Lu Liang began to think. It could be seen that Novartis was now in a hurry.
But it's also normal.
Both Beshuk and Gleevec are drugs for the treatment of chronic myelogenous leukemia. Two drugs with the same effect, Beshuk only costs 500 a bottle, but Gleevec sells for 40,000 a bottle.
Under the impact of Bai Shuke, no patients come back to buy Gleevec. Can Novartis not be in a hurry?
Lu Liang said slowly: What conditions do they offer, Teacher Ji?
Although Lu Liang had no intention of transferring the patent, he still wanted to hear Novartis' conditions.
After Ji Hong was silent for a moment, he slowly said: The condition offered by Novartis is that the patent transfer fee is tens of billions.
Hiss~!
Lu Liang couldn't help but take a breath at Novartis' conditions. Although he knew that Novartis had always been wealthy, this condition still made Lu Liang tremble in his heart.
Ten billion, what a concept.
One hundred million hundred dollar bills, based on the 10cm thickness of one thousand hundred dollar bills, tens of billions stacked together are equivalent to the altitude of the Himalayas.
If this amount of money were spread out, it would be enough to circle a quarter of the way around the equator.
However, Lu Liang was a little confused. Didn't Novartis own the patent for Gleevec? Why would they want to buy the drug patent for Beishuke?
After all, these two drugs are drugs for the treatment of chronic myelogenous leukemia. Even if they buy them, they can't make twice as much money.
But this doubt only lasted for a moment, and Lu Liang quickly figured out Novartis's intentions.
Even if he sells Bai Shuke's drug patent to Novartis, Novartis will not use the patent to produce pharmaceuticals. Instead, it will throw Bai Shuke's patent into a box and collect dust.
Because Bai Shuke's patent is not important to Novartis at all.
There is no Beishuke, which is very important for Novartis!
The reason why Gleevec dares to sell 40,000 bottles is not because it has a monopoly position in the treatment of chronic myeloid leukemia.
And now the emergence of Bai Shuke has directly broken Gleevec's monopoly.
This undoubtedly kicked Gleevec directly from heaven into the stinking ditch.
If Novartis wants to continue selling Gleevec at a sky-high price of 40,000 a bottle, the first thing it has to do is get rid of Bai Shuke.
The best way is to buy Bai Shuke's patent.
This patent may not be of much help to Novartis, but as long as the patent is in hand, no company can continue to produce Beishok, otherwise it will face sky-high claims from Novartis.
Ten billion is certainly an astronomical figure, but for Novartis, this huge amount of money does not even account for Novartis's annual profit in the domestic market.
Therefore, as long as there is no Bai Shuk on the market, Novartis can easily make up for its losses with 40,000 bottles of Gleevec.
If you were an ordinary person, you would probably agree after facing the sky-high price offered by Novartis.
But Lu Liang is different. He is not short of money now.
In other words, what Lu Liang really needs is not money.
If he really wants to make money, he can raise the price of Bai Shuke, or sell it for 40,000 bottles like Gleevec. He is fully capable of making enough money.
But he doesn't need to.
The only thing he needs now is the source point, which can help him continuously analyze the source point of new drugs.
As long as there are enough sources, he will be able to continuously produce new drugs, and making money will be easy.
But now, as Bai Shuke can continuously provide him with sources of resources, how could Lu Liang transfer it so easily.
Ji Hong was silent for a moment and then asked: Xiao Lu, have you thought about it?
Think about it, teacher. Lu Liang replied calmly.
Listening to Lu Liang's voice on the other end of the phone, Ji Hong couldn't help but sigh. He could probably guess the decision Lu Liang made. No one could stay calm in the face of such an astronomical figure.
As long as Lu Liang nods and agrees now, he can get the astronomical figure given by Novartis.
Assuming that Lu Liang can live for another 70 years, he will have to spend 400,000 yuan every day for the rest of his life to spend all the money!
This does not include the interest accrued after the money is deposited in the bank.
In other words, Lu Liang's only job for the rest of his life is to spend money.
Not to mention Lu Liang, even Ji Hong himself felt a little moved by this kind of life.
But, I refuse!
Ji Hong on the other end of the phone sighed: I can understand, Novartis does give you a lot. Wait, no, Xiao Lu, what did you just say?
Halfway through Ji Hong's words, his tone suddenly rose.
Lu Liang couldn't help but put the phone away: Teacher, I say, I refuse.
Ji Hong suspected that there was something wrong with his ears. In his opinion, it was impossible for Lu Liang to refuse the conditions offered by Novartis.
But now Lu Liang not only refused, but he refused simply and neatly, as if he had not considered Novartis' conditions at all.
This made Ji Hong a little unbelievable.